Filtyp
Professor Sophia Zackrisson has been appointed as the new LUCC coordinator for a 3-year period and she will replace Kristian Pietras as coordinator from March 1st 2021. Nomination of coordinator candidates took place during December 2020 until the end of February 2021 and the Dean of Faculty of Medicine appointed the new coordinator in March. Sophia Zackrisson is part of the LUCC steering group an
https://www.lucc.lu.se/article/new-lucc-coordinator - 2025-10-03
In May, screening for colorectal cancer will be offered in Skåne to all those born in 1961. Subsequently, Swedes aged 60 to 74 will be tested for blood in their faeces, to detect cancer at an early stage. Once all regions in Sweden have introduced the screening, at least 300 lives are expected to be saved per year. Sweden has been slow to introduce screening; this spring, Skåne will become the thi
https://www.lucc.lu.se/article/screening-colorectal-cancer-starts-spring - 2025-10-03
3D-mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology. “Our results indicate that 3D-mammography, or digital breast tomosynthesis, possibly detects cancers that would otherwise have been diag
https://www.lucc.lu.se/article/fewer-breast-cancer-cases-between-screening-rounds-3d-mammography - 2025-10-03
A small proportion of women who receive anti-estrogen treatment after breast cancer surgery have worse outcomes. This is associated with mutations in the estrogen receptor gene, according to a study from Lund University now published in JNCI Cancer Spectrum. “If our results are confirmed in further studies, it would be relevant to screen for these resistance mutations already at diagnosis, and t
https://www.lucc.lu.se/article/mutations-can-reduce-effect-hormonal-treatment-early-breast-cancer - 2025-10-03
Pia Sundgren has been elected as Senior Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) and Titti Owman recieved Distinguished Service Award from the Society for MR Radiographers & Technologist (SMRT). Pia C. Maly Sundgren, M.D., Ph.D., Lund University, Lund, Sweden has been elected as Senior Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM
https://www.lucc.lu.se/article/elected-senior-fellow-and-distinguished-service-award-lund - 2025-10-03
Skåne University Hospital is in a process to establish a Comprehensive Cancer Centre. A digital site visit by the Organisation of European Cancer Institutes (OECI) took place 22-24 June, 2021 as part of the accreditation process to establish a Comprehensive Cancer Centre at Skåne University Hospital. OECI has an accreditation programme to implement quality in cancer care. Skåne University Hospital
https://www.lucc.lu.se/article/accreditation-process-improve-cancer-care-skane-university-hospital - 2025-10-03
Congratulations Anna Blom, Professor of Medical Protein Chemistry at Lund University and the recipient of the Swedish Society of Medicine’s Berzelius Medal in Gold 2021 for innovative research in the field of medical chemistry. How does it feel to receive this prestigious award? – It’s a great honour for me to be awarded the Berzelius Medal and for our research to receive such notice. I began my p
https://www.lucc.lu.se/article/anna-blom-receives-2021-berzelius-medal-advances-medical-chemistry - 2025-10-03
Information about the Advanced Cancer Biology course VMFN29 (30 ECTS) can be found here The application period is from October 18th 2021 to January 17rd 2023 and you apply in the international admission portal The course period is from August 29th 2022 to January 23rd 2023.
https://www.lucc.lu.se/article/international-admission-advanced-cancer-biology-course-open - 2025-10-03
With 10,000 new cases a year, prostate cancer is the most common cancer type in Sweden. To create equal, accessible and high-quality prostate cancer care, Region Skåne has introduced Organised prostate cancer testing, OPT. "Anyone who wants to should be allowed to be tested for prostate cancer. Studies show that early detection lowers long-term mortality", says Anders Bjartell, one of Sweden’s lea
https://www.lucc.lu.se/article/organised-prostate-cancer-testing-provide-more-equal-care - 2025-10-03
Congratulations to Göran Jönsson who receives this year's Göran Gustafsson Prize in medicine. The prize is awarded by the Royal Academy of Sciences and is awarded to younger researchers who have achieved great success in their field. Göran Jönsson, professor in molecular oncology at Lund University, receives the award "for his pioneering work in describing the genetic and molecular landscape, as w
Alexander Pietras, Associate Professor at Lund University, have been awarded an European Research Council Consolidator Grant (ERC-CoG) for the project - RESISTANCEPROGRAMS. The research group will explore and exploite the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors. Glioblastoma multiforme (GBM), the deadliest form of brain tumor, occurs in both
https://www.lucc.lu.se/article/euroupean-research-council-consolidator-grant-alexander-pietras - 2025-10-03
In a recent study from Lund University in Sweden, researchers discovered that metabolic changes affect how blood cells are formed during embryonic development. They found a previously unknown metabolic switch with a key role in how different types of blood cells develop. This means blood cell formation can be directed towards producing natural killer cells in the laboratory to ultimately be used i
https://www.lucc.lu.se/article/metabolism-found-regulate-production-killer-cells - 2025-10-03
In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as targets for immunotherapies. A research group
https://www.lucc.lu.se/article/new-precision-technology-immunotherapy - 2025-10-03
Smokers have a lower risk of developing prostate cancer, but a higher risk of dying from the disease, according to a large population study led by Lund University in Sweden. The researchers followed more than 350 000 people over several decades, and the results are now published in European Urology. It is well known that smokers have an increased risk of developing various cancers, but there have
https://www.lucc.lu.se/article/smoking-worsens-prognosis-men-prostate-cancer - 2025-10-03
Skåne University Hospital Cancer Centre (SUHCC) has been accredited as Comprehensive Cancer Centre (CCC) by the Organisation of European Cancer Institutes (OECI). The accreditation as Comprehensive Cancer Centre means that an organisation has been approved according to the highly set quality criteria of the Organisation of European Cancer Institutes (OECI). Skåne University Hospital Cancer Centre
https://www.lucc.lu.se/article/skane-university-hospital-cancer-centre-accredited-comprehensive-cancer-centre - 2025-10-03
By using cells isolated from cancer patients and mixing them with a new technology called “OssiGel”, it is possible to engineer human mini-bones. These miniaturized organs consist of mature bone and marrow tissue and can be used as model to study the disease mechanisms behind cancers that arise in bone marrow or spread to the bones, and offer the personalized testing of new drugs. Paul Bourgine is
https://www.lucc.lu.se/article/miniature-bones-research-model-cancer - 2025-10-03
The environment in which breast cancer arises –the interplay between the patient’s BMI, tumour size and cancer-specific proteins –is of importance for the prognosis. This is shown in a study from Lund University in Sweden. The knowledge could further enhance precision medicine in breast cancer. Major advances in diagnostics and treatment have improved survival rates among breast cancer patients in
https://www.lucc.lu.se/article/tumour-environment-can-affect-breast-cancer-prognosis - 2025-10-03
Göran Jönsson, professor of molecular oncology, receives SEK 31 million from the Knut and Alice Wallenberg Foundation to enhance the effect of immunotherapy in the treatment of cancer patients. About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time, this means that 70 per cent of all melanoma patients still have no effective treatment option. Göran Jöns
https://www.lucc.lu.se/article/sek-31-million-enhance-effect-immunotherapy-treatment-cancer-patients - 2025-10-03
Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. The results have been published in Science Advances. Neuroblastoma is an aggressive cancer of the sympathetic nervous system, especially of the adrenal gland. Despite intense
https://www.lucc.lu.se/article/altered-cell-behaviour-behind-resistance-neuroblastoma - 2025-10-03
Stem cells programmed to produce insulin in people with type 1 diabetes or to repair the heart muscle after a heart attack. Gene and cell therapies that improve cancer treatments. These new and innovative therapies have the potential to cure, alleviate and treat diseases where traditional medicines are currently insufficient. The monk Gregor Mendel set more in motion than he could have imagined wh
https://www.lucc.lu.se/article/advanced-treatments-future-are-soon-here - 2025-10-03
